SPOTLIGHT: BMS selling off ConvaTec unit for $4.1B

Bristol-Myers Squibb continues to off-load parts of its business that aren't directly related to its beef-up-biopharma strategy: the company has agreed to sell its wound and ostomy care division ConvaTec to a private equity partnership for $4.1 billion. Release | Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.